Search Orphan Drug Designations and Approvals
-
Generic Name: | Paxalisib (INN and USAN) |
---|---|
Date Designated: | 06/15/2022 |
Orphan Designation: | Treatment of atypical teratoid/rhabdoid tumors (AT/RT) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Kazia Therapeutics Limited ACN 063 259 754 Level 24, 300 Barangaroo Avenue Sydney, New South Whales 02000 Australia The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-